Description

7-[(3-Chloro-6-Methyl-5,5-Dioxidodibenzo[C,F][1,2]Thiazepin-11(6H)-Ylidene)Amino]Heptanoic Acid is a high-purity, synthetic organic compound belonging to the dibenzothiazepine class, valued for its role as a key pharmaceutical intermediate. Its complex heterocyclic structure makes it a critical building block in the research and development of novel therapeutic agents. This compound is primarily targeted at R&D laboratories and production facilities in the global pharmaceutical and fine chemical industries.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of active pharmaceutical ingredients (APIs), particularly for central nervous system (CNS) and psychotropic drug candidates.
• Medicinal Chemistry Research: Used as a scaffold or building block for designing and optimizing new chemical entities with potential biological activity.
• Biochemical Research: Employed in studies investigating receptor-ligand interactions and structure-activity relationships (SAR) due to its specific molecular architecture.
• Fine Chemical Synthesis: Acts as a specialized intermediate in multi-step organic synthesis for producing complex, high-value molecules.
• Reference Standard: Supplied as a certified reference material (CRM) for analytical method development, validation, and quality control in pharmaceutical analysis.

Basic Information

Product Name	7-[(3-Chloro-6-Methyl-5,5-Dioxidodibenzo[C,F][1,2]Thiazepin-11(6H)-Ylidene)Amino]Heptanoic Acid
CAS No.	131206-48-9
Molecular Formula	C21H21ClN2O4S
Molecular Weight	432.92 g/mol
Synonyms	11-(7-Carboxyheptylideneamino)-3-chloro-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide; 7-[(3-Chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-ylidene)amino]heptanoic acid; Dibenzo[c,f][1,2]thiazepin-11(6H)-one, 7-[(3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-ylidene)amino]heptanoic acid deriv.; Heptanoic acid, 7-[(3-chloro-6-methyl-5,5-dioxidodibenzo[c,f][1,2]thiazepin-11(6H)-ylidene)amino]-
EINECS	Contact for details

Quality Control

Our production of 7-[(3-Chloro-6-Methyl-5,5-Dioxidodibenzo[C,F][1,2]Thiazepin-11(6H)-Ylidene)Amino]Heptanoic Acid adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via IR and NMR spectroscopy, to ensure it meets the exacting standards required for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with every shipment, guaranteeing traceability and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to ensure stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.